-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it
Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
Polymeric bioadhesive emulsions and suspensions and methods of treatment
Topical drug delivery composition and method
Sulfated hyaluronic acid and esters thereof Patent #: 6339074
ApplicationNo. 10035753 filed on 12/21/2001
US Classes:514/54, Polysaccharide514/62, Glucosamine or derivative514/420, Indomethacine per se or ester thereof514/427, Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.)514/560, Carbon to carbon unsaturation536/55.1, Polysaccharides536/55.2, Glucosamine containing536/55.3, Processes536/123.1, Polysaccharides424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/456Gelatin
ExaminersPrimary: Wilson, James O.
Assistant: McIntosh, III, Traviss C.
Attorney, Agent or Firm
Foreign Patent References
International ClassesA01N 4304
AbstractAn orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the softening of the human skin.
Field of SearchPolysaccharide
Glucosamine or derivative
Indomethacine per se or ester thereof
Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.)
Carbon to carbon unsaturation
Capsules (e.g., of gelatin, of chocolate, etc.)
Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof (e.g., chocolate)